![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 53, 37750-37754, December 31, 1999
From the Department of Microbiology and Immunology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232-2363
| |
ABSTRACT |
|---|
|
|
|---|
We have performed a site-directed mutagenesis
study showing that residues comprising the type I signal peptidase
signature in the two catalytic subunits of the yeast inner membrane
protease, Imp1p and Imp2p, are functionally important, consistent with
the idea that these subunits contain a serine/lysine catalytic dyad. Previous studies have shown that Imp1p cleaves signal peptides having
asparagine at the The type I signal peptidase family consists of enzymes located in
the plasma membranes of eubacterial cells, the endoplasmic reticulum
(ER)1 membrane, and the inner
membrane of mitochondria. These enzymes function similarly to cleave
signal peptides from the amino termini of precursor proteins after the
delivery of these precursors to their appropriate cellular compartments
(reviewed in Ref. 1). Based on the crystal structure of leader
peptidase from Escherichia coli (2), the eubacterial signal
peptidases exhibit five characteristic residues that make up a type I
signature sequence consisting of a serine/lysine catalytic dyad and
three structurally important amino acids, an arginine and two aspartic
acids, that are positioned close to the catalytic site. The ER homolog
of the eubacterial signal peptidases, Sec11p, has a similar signature;
however, Sec11p contains histidine in place of lysine. Because this
histidine is important for catalysis (3), Sec11p may utilize a
serine/histidine dyad or a catalytic triad of serine/histidine/aspartic
acid. The type I signal peptidase found in the inner membrane of
mitochondria consists of two subunits, both of which are catalytic
(4-6). Termed inner membrane protease (IMP), sequence comparisons
suggest that the IMP subunits, Imp1p and Imp2p, may contain
serine/lysine dyads, like their eubacterial counterparts (1).
Imp1p from the yeast Saccharomyces cerevisiae cleaves the
signal peptides from the precursors to cytochrome (cyt)
b2, a nuclear encoded protein, and cyt oxidase
subunit II, a protein encoded within the mitochondrion. The signal
peptides of these precursors possess asparagine at the In agreement with the Yeast Strains, Media, and Antibodies--
Media for growing
yeast (13) and glycerol-containing media (5) have been described. A rat
anti-HA antibody (clone 3F10; Roche Molecular Biochemicals) was used in
this study. Yeast strain JNY34 (MATa imp2 Biochemical Procedures--
Pulse-chase methods have been
published (13, 15). For immunoprecipitation analysis, the procedure
published previously (15) was used, except for the following
modifications. Anti-HA antibodies and protein G (instead of protein
A)-Sepharose were used. After the wash of the protein G-Sepharose
pellet, the material was resuspended in 0.1 ml of 1% SDS, 50 mM Tris (pH 7.5) and boiled for 4 min. PBS containing 1%
Triton X-100 (1.0 ml) and a protease inhibitor mixture (15) was added.
The mixture was vortexed briefly in an Eppendorf tube and placed on ice
for 10 min. The tube was subjected to centrifugation (14,000 × g) for 10 s, and the supernatant was transferred to a
new Eppendorf tube. A second aliquot of anti-HA antibody (2 µg/3
A600 cell equivalents) was added, and the
immunoprecipitation procedure described previously (15) was followed.
Epitope Tagging--
Protein tagging using the HA epitope (16)
was performed as follows. The CYB2 gene encoding the
precursor to cyt b2 was amplified by the
polymerase chain reaction using upstream primer
TCCCCCGGGATGCTAAAATACAAACCTTTAC containing a SmaI site and
downstream primer
GCGAATTCTTACGCGTAGTCTGGGACGTCGTATGGGTATGCATCCTCAAATTCTGTTAAAGTAGGTCCC containing a EcoRI site and encoding the HA epitope.
The product was inserted between the SmaI and
EcoRI sites of pHF454 (2 µm TRP1) (3), which
placed the CYB2 coding sequence immediately downstream of
the ADH1 promoter (17).
The CYT1 gene encoding the precursor to cyt
c1 was amplified using upstream primer
CGGGATCCATGTTTTCAAATCTATCTAAACG containing a BamHI
site and downstream primer
GCGAATTCTTACGCGTAGTCTGGGACGTCGTATGGGTACTTTCTTGGTTTTGGTGGATTGAAAACG containing a EcoRI site and encoding the HA epitope.
The product was inserted between the BamHI and
EcoRI sites of pHF454 (2 µm TRP1) immediately
downstream of the ADH1 promoter.
Site-directed Mutagenesis--
All site-directed mutagenesis
reactions were performed as described previously (3). The wild-type
IMP1 gene and the mutations constructed in IMP1
were introduced into pRS426 (2 µm URA3) (18). The DNA
fragment that was used included the native IMP1 promoter carried by a 400-nucleotide stretch upstream of the Imp1p coding sequence. The wild-type IMP2 gene and the mutations
constructed in IMP2 were introduced into pHF455 (2 µm
URA3), which placed the IMP2 coding sequence
immediately downstream of the ADH1 promoter. To mutagenize
CYB2, the wild-type CYB2 gene and the mutations constructed in CYB2 (tagged with a sequence encoding the HA
epitope as described above) were introduced into pHF454 (2 µm
TRP1), which placed the CYB2 gene downstream of
the ADH1 promoter. To mutagenize CYT1, the
wild-type CYT1 gene and the mutations constructed in CYT1 (tagged with a sequence encoding the HA epitope as
described above) were introduced into pHF454 (2 µm TRP1),
placing the CYT1 gene immediately downstream of the
ADH1 promoter. The sequences of the oligonucleotides used to
construct these mutations are available upon request.
Amino Acids Comprising the Type I Signal Peptidase Signature Are
Important for Imp1p and Imp2p Function--
Five key amino acids have
been found to serve critical roles in catalysis and structural
maintenance of the type I signal peptidases in eubacteria, including
leader peptidase from E. coli (2, 19-21) and SipS from
Bacillus subtilis (22). This signature sequence includes the
catalytic dyad residues, serine and lysine, and three amino acids, an
arginine and two aspartic acids, that are structurally important (Fig.
1). Because Imp1p and Imp2p of the
mitochondrial signal peptidase from the yeast S. cerevisiae contain this signature, we asked whether these five amino acids were
important for enzyme function using a site-directed mutagenesis approach. Mutations altering these five residues were constructed in
the IMP1 gene and inserted into pRS426 (2 µm
URA3) (see "Experimental Procedures"). The constructs
were then introduced into yeast strain XCY101
(imp1::HIS3). The genotypes of strains used in
this study are listed under "Experimental Procedures." To determine
whether these mutations inhibited enzyme activity, a pulse-chase assay was used to monitor for cleavage of the Imp1p substrate
i-cyt b2. Pre-cyt
b2 (p-cyt b2)
contains a bipartite signal sequence (23). The amino-terminal half is
cleaved by the mitochondrial processing protease (
After the 60-min chase, mature cyt b2HA
(m-cyt b2HA) was present in cells
carrying the wild-type IMP1 gene, whereas the intermediate species, but no mature species, was found in XCY101 cells
(imp1::HIS3) lacking Imp1p (Fig.
2). The p-cyt
b2HA protein containing the bipartite signal was
not detected under these conditions. In cells carrying the S40A, S40T,
K84R, K84H, D131Y, D138N, and D138E mutations, i-cyt
b2HA was seen exclusively, indicating a strong
inhibition of cleavage by these mutated forms of Imp1p. In agreement
with this result, yeast cells bearing these imp1 mutations
were not viable on agar plates containing glycerol, a nonfermentable
carbon source. Imp1p is required for cellular respiration, probably
because at least one of the Imp1p substrates is nonfunctional when its signal peptide is still attached. Therefore, growth of yeast cells in
the presence of a nonfermentable carbon source is an indicator of Imp1p
function (4, 5). The remaining imp1 mutations (D131N, D131E,
and R85A) inhibited the cleavage of i-cyt
b2HA less well (Fig. 1). Furthermore, yeast
cells bearing these mutations were able to grow on agar plates
containing glycerol as the sole carbon source. Taken together, all five
amino acids comprising the type I signature of Imp1p were important for
function, although Asp131 could be changed to asparagine
and glutamic acid without appreciable loss of activity, and
Arg85 could be changed to alanine, resulting in only a
partial enzymatic defect.
We next asked whether the type I signature amino acids in Imp2p were
important for its function. A series of imp2 mutations was
constructed by site-directed mutagenesis. The IMP2 gene and the imp2 mutations were introduced into pHF455 (2 µm
URA3) (see "Experimental Procedures"). This plasmid
series was then introduced into strain JNY34 (imp2
When the wild-type IMP2 gene was present in cells, a large
amount of m-cyt c1HA was exhibited
(Fig. 3). These cells also displayed both
p-cyt c1HA, which contains a
bipartite signal peptide (28), and i-cyt
c1HA, which contains the second half of the
bipartite signal. The presence of these two immature species in cells
containing wild-type Imp2p may be due to the fact that the
CYT1 gene was overexpressed (see "Experimental
Procedures" for a description of the plasmid used). A novel species
of slightly smaller molecular mass than m-cyt
c1HA was also present in cells containing
wild-type Imp2p (Fig. 3, see lane IMP2(wt)). The identity of
this novel form is not known; however, it may represent a proteolytic
fragment arising from overexpression of the apoprotein. In JNY34
(imp2
None of these imp2 mutations inhibited the growth of JNY34
cells on agar plates containing glycerol, consistent with the fact that
Imp2p activity is nonessential for cellular respiration (5). However, a
physical interaction between Imp1p and Imp2p is important for the
stability of Imp1p and thus for the growth of yeast cells in the
presence of a nonfermentable carbon source (5). The fact that none of
the imp2 mutations inhibited the growth of JNY34 cells in
the presence of glycerol suggests that the imp2 mutations did not prevent the binding of Imp2p to Imp1p. Indeed, we have shown
that Imp2p containing the above-mentioned mutations altering Ser41 or Lys91 was stable in yeast cells for at
least 30 min, whereas mutations altering Arg92,
Asp124, and Asp131 led to the degradation of
Imp2p in vivo (data not shown).
In summary, the data show that, as with Imp1p, the five amino acids
comprising the type I signature of Imp2p are important for its
enzymatic activity. Considering that mutations altering Ser41 and Lys91 of Imp2p inhibit enzyme
activity completely but do not affect Imp2p stability in
vivo, Imp2p and, by extension, Imp1p probably contain a
serine/lysine catalytic dyad.
Imp1p Cleaves Signal Peptides Containing Standard and Nonstandard
Cleavage Sites--
Imp2p cleaves the signal peptide of
i-cyt c1 that contains the
As shown in Fig. 4A, the
placement of five different amino acids into the signal peptide of
i-cyt b2HA led to its efficient cleavage by Imp1p. Serine, cysteine, methionine, alanine, and leucine
were tolerated almost as well as the naturally occurring asparagine
residue. Only a small amount of cleavage of i-cyt
b2HA by Imp1p was detected when glutamine and
threonine were present and no cleavage was detected when any other
amino acid was present at the
We next introduced this series of mutations into cells of strain XCY101
(imp1::HIS3), and then we performed a pulse-chase analysis to determine whether Imp2p could cleave these mutant forms of
i-cyt b2HA. As shown in Fig.
4B, Imp2p was unable to cleave i-cyt
b2HA containing any amino acid at the
We reasoned that the introduction of a
The data presented in Fig. 4B show that, surprisingly, Imp2p
could not cleave i-cyt b2HA that had
alanine at the In this study, we have asked whether amino acids comprising the
type I signal peptidase signatures of the IMP subunits are functionally
important. Studies in eubacterial systems have shown that the type I
signature consists of a serine, lysine, arginine, and two aspartic acid
residues that are important for the function of leader peptidase from
E. coli and SipS from B. subtilis (21, 22). Imp1p
and Imp2p from the yeast mitochondrion contain similar signatures (Fig.
1); however, functional studies have been lacking, except for an
analysis of Ser41, which has been shown to be essential to
Imp2p (5). Here, we have demonstrated that conservative changes of the
signature serine and lysine residues of Imp1p (Fig. 2) and Imp2p (Fig.
3) abolish their enzymatic activity. Moreover, Imp2p containing
conservative changes of the signature serine and lysine residues is
stable in vivo (data not shown), consistent with studies in
eubacterial systems showing that the corresponding residues make up a
catalytic serine/lysine dyad (2, 21, 22). In the eubacterial studies, the remaining amino acids, an arginine and two aspartic acid residues, are important structural amino acids, and from the data presented here,
it is plausible that the corresponding amino acids in Imp1p and Imp2p
serve a similar role. Considering these results, Imp1p and Imp2p
contain similar type I signatures, although they cleave different
signal peptides inside the mitochondrion.
Another goal of this study is to understand why Imp1p and Imp2p exhibit
nonoverlapping substrate specificities. To this end, we have tested the
hypothesis that the presence of asparagine at the A caveat to this conclusion is that without amino-terminal sequencing
of the cleavage product, we cannot be absolutely certain that cleavage
did not occur at a nearby asparagine residue in the linear amino acid
sequence. However, 14 amino acid substitutions at the Although the Imp2p substrate i-cyt c1
contains alanine at the Thus, the goal of identifying factors that govern the substrate
specificities exhibited by the IMP subunits has been achieved only
partially in this study. We have shown that amino acids at the
1 position, which deviates from the typical signal
peptide possessing a small uncharged amino acid at this position. To
determine whether asparagine is responsible for the nonoverlapping
substrate specificities exhibited by the inner membrane protease
subunits, we have substituted asparagine with 19 amino acids in the
Imp1p substrate i-cytochrome (cyt) b2. The resulting signal peptides containing
alanine, serine, cysteine, leucine, and methionine can be cleaved
efficiently by Imp1p. The remaining mutant signal peptides are cleaved
inefficiently or not at all. Surprisingly, none of the amino acid
changes results in the recognition of i-cyt
b2 by Imp2p, whose natural substrate, i-cyt c1, has alanine at the
1
position. The data demonstrate that (i) although the
1 residue is
important in substrates recognized by Imp1p, signal peptides having
standard and nonstandard cleavage sites can be processed by Imp1p, and
(ii) a
1 asparagine does not govern the substrate specificity of the
inner membrane protease subunits.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 position
from the cleavage site (4). The presence of a
1 asparagine in the
Imp1p substrates violates the "
1,
3 rule" proposed in previous
studies (7-9), which is based on the fact that signal peptides in the
eubacterial and ER systems contain small uncharged amino acids at the
1 position and, to a lesser extent, the
3 position. Indeed,
site-directed mutagenesis studies have confirmed the critical role of
the
1 amino acid for the correct cleavage of signal peptides in the ER and in eubacterial cells (10-12). From the crystallographic analysis of leader peptidase, the
1 and
3 amino acids probably help
to position the signal peptide relative to the active site through
their interactions with distinct binding pockets on the enzyme's
surface (2).
1,
3 rule, Imp2p cleaves a more conventional
signal peptide such as that of the cyt c1
precursor, which has alanine at the
1 position (5). A reasonable
hypothesis to explain why Imp1p cleaves a different signal peptide from
that of Imp2p is that Imp1p is able to recognize a
1 asparagine (5). An extension of this idea is that asparagine may fit into the appropriate binding pocket of Imp1p and be excluded from the
corresponding site in Imp2p. To address this hypothesis, we have asked
the following question: do mutations affecting the
1 asparagine of
the cyt b2 precursor inhibit its cleavage by
Imp1p and, conversely, allow for its cleavage by Imp2p? We have also
asked whether the type I signature sequences of Imp1p and Imp2p are
important for their enzymatic activities.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-1 ura3-52
trp1) was obtained from Jodi Nunnari (University of California,
Davis, CA). Strain XCY101 (MAT
imp1::HIS3 ura3-52
leu2-3,112 his3-
200 trp1-
901
suc2-
9 lys2-80) was constructed as follows. A
BamHI fragment encoding the HIS3 gene (14) was inserted into the BamHI site of IMP1, which
corresponds to amino acid 97. A linear DNA fragment containing the
IMP1 gene disrupted with HIS3 was introduced by
homologous recombination into the chromosome of strain SEY6210
(MAT
ura3-52 leu2-3,112 his3-
200 trp1-
901 suc2-
9 lys2-80) (14). The
disruption was confirmed by the fact that strain XCY101 failed to grow
in glycerol-containing media, and this growth defect was complemented
by plasmids bearing the wild-type IMP1 gene.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
) within the
mitochondrial matrix (24-27). This cleavage event liberates an
intermediate form, i-cyt b2, that
contains the second half of the bipartite signal, which is cleaved by
Imp1p. Cells of strain XCY101 bearing the imp1 mutations and
bearing pXC2 (2 µm TRP1) that contained the wild-type
CYB2 gene (encoding p-cyt
b2 that had been tagged at the carboxyl terminus with the HA epitope) (see "Experimental Procedures") were grown to
log phase in a glucose-containing medium and treated with a 10-min
pulse using [35S]methionine and
[35S]cysteine, followed by a 60-min chase with excess
unlabeled methionine and cysteine. Proteins were precipitated from cell
extracts using anti-HA antibodies and subjected to SDS-PAGE and
fluorography.
![]()
View larger version (11K):
[in a new window]
Fig. 1.
Regions of homology among members of the type
I signal peptidase family. Box I, Box II, and
Box III represent sequences that are homologous in leader
peptidase from E. coli, SipS from B. subtilis,
and the Imp1p and Imp2p subunits of the yeast IMP. The positions of the
catalytic serine and lysine of leader peptidase are indicated (*),
and the amino acids important for maintaining the structure of leader
peptidase are indicated (#). Gaps in these sequences are indicated by a
dash.
![]()
View larger version (6K):
[in a new window]
Fig. 2.
Processing of the cyt
b2 precursor by mutant forms of
Imp1p. Processing of the cyt b2 precursor
tagged with the HA epitope was examined in XCY101 cells
(imp1::HIS3)/pXC2 (CYB2-HA
TRP1) bearing a URA3-marked plasmid containing
the wild-type (wt) IMP1 gene or one of a number
of imp1 mutations that are indicated at the top of the
figure (see "Experimental Procedures"). Cells were subjected to a
10-min pulse and a 60-min chase, and proteins were precipitated using
anti-HA antibodies (see "Experimental Procedures"). Intermediate
(i) and mature (m) cyt b2
were resolved on a 7% SDS-PAGE gel. Each lane represents two
A600 equivalents of log-phase yeast cells.
),
which contained pXC1 (2 µm TRP1) that bore the
CYT1 gene (encoding p-cyt
c1 that had been tagged at the carboxyl terminus
with the HA epitope) (see "Experimental Procedures"). Cells were
grown in a medium containing glucose and then subjected to a 15-min
pulse and a 30-min chase.
) cells lacking Imp2p, m-cyt
c1HA was absent (Fig. 3). Likewise, little or no
production of m-cyt c1HA was detected
in cells carrying the S41A, S41T, K91R, K91H, D124N, D124Y, D131N, and
D131E mutations. One of these mutations, the S41A mutation, was also
constructed in a previous study, and results similar to those reported
here were obtained (5). The R92A and D124E mutations only partially inhibited the production of m-cyt
c1HA (Fig. 3).
![]()
View larger version (9K):
[in a new window]
Fig. 3.
Processing of the cyt
c1 precursor by mutant forms of
Imp2p. Processing of the cyt c1 precursor
tagged with the HA epitope was examined in JNY34 cells
(imp2
)/pXC1 (CYT1-HA TRP1) bearing
a URA3-marked plasmid containing the wild-type
(wt) IMP2 gene or one of a number of
imp2 mutations that are indicated at the top of the figure
(see "Experimental Procedures"). Cells were subjected to a 15-min
pulse and a 30-min chase, and proteins were precipitated using anti-HA
antibodies (see "Experimental Procedures"). The precursor
(p) containing a bipartite signal sequence, an intermediate
(i) form containing only the second half of the bipartite
signal, and mature (m) cyt c1 were
resolved on a 10% SDS-PAGE gel. A novel species of unknown origin is
sometimes seen below the band labeled m. Each lane
represents three A600 equivalents of log-phase
yeast cells.
1
residue, alanine, whereas Imp1p cleaves the signal peptide of
i-cyt b2 that has a nonstandard
1
residue, asparagine. Because current models suggest that asparagine may
provide a determinant for this substrate specificity, we prepared a
series of constructs that introduced 19 amino acids into the
1
position of i-cyt b2HA to identify
amino acid substitutions that inhibit cleavage by Imp1p and promote
cleavage by Imp2p. These changes were constructed by site-directed
mutagenesis (see "Experimental Procedures"). To determine whether
Imp1p was able to cleave signal peptides containing these amino acid
substitutions, a series of plasmids was introduced into cells of strain
JNY34 (imp2
). Because Imp1p is unstable in the absence of
Imp2p, the cells also carried plasmid pXC3 that contained the
imp2 (S41A) mutation. This mutation renders Imp2p
enzymatically inactive (see Fig. 3) but does not affect Imp2p stability
and thus Imp1p stability (5). Cells were grown to log phase and
subjected to a 10-min pulse followed by a 60-min chase, and proteins
were precipitated from cell extracts using anti-HA antibodies.
1 position (Fig. 4A). The
inhibition of cleavage by 14 different amino acid substitutions at the
1 position argues against the idea that cleavage can occur at a
nearby asparagine when serine, cysteine, methionine, alanine, and
leucine are present.

View larger version (37K):
[in a new window]
Fig. 4.
Cleavage of
1 mutant
forms of p-cyt b2. A
series of TRP1-based plasmids encoding the cyt
b2HA precursor containing 20 different amino
acids at the
1 position (indicated by the one-letter code) was
introduced into strain JNY34 (imp2
)/pXC3 (imp2
(S41A) URA3) (A) and strain XCY101
(imp1::HIS3) (B). Strain JNY34
(imp2
)/pXC3 (imp2 (S41A) URA3)
containing the wild-type cyt b2HA precursor is
depicted in the first lane of B. Cells were
subjected to a 10-min pulse and a 60-min chase, and proteins were
precipitated using anti-HA antibodies. The precursor (p),
intermediate (i), and mature (m) forms of cyt
b2 were resolved on a 7% SDS-PAGE gel. Each
lane represents two A600 equivalents of
log-phase yeast cells.
1 position.
1 methionine into
i-cyt b2HA may result in a new
translational start site, which could be mistaken for cleavage at the
1 site by Imp1p (Fig. 4A). We therefore repeated the
pulse-chase analysis, only this time, proteins were immunoprecipitated
from cell extracts of strain JNY34 (imp2
)/pXC3 (imp2 (S41A)) after both the pulse and the chase. The
p-cyt b2HA protein was present after
the pulse, and m-cyt b2HA was present after a 30-min chase (data not shown). This precursor-product relationship established that a cleavage event had occurred, supporting the idea that Imp1p can cleave i-cyt
b2HA after the
1 methionine. Further support
for this conclusion comes from the fact that a protein having the size
of m-cyt b2HA was absent from strain
XCY101 (Fig. 4B).
1 position. Because the natural substrate for Imp2p,
i-cyt c1, contains a
1 alanine, we
chose to examine the
3 residue of i-cyt
b2HA. Both of the Imp1p substrates,
i-cyt b2 and p-cyt oxidase
subunit II, contained isoleucine at the
3 position, whereas the Imp2p substrate had a
3 alanine. It thus seemed plausible that in order to
promote cleavage of i-cyt b2 by
Imp2p, it may be necessary to change the
1 and
3 amino acids to
alanine. To this end, we constructed a series of mutations in which
different combinations of asparagine and alanine were placed at the
1
position, and different combinations of isoleucine and alanine were
placed at the
3 position of i-cyt
b2HA. The mutations were introduced into plasmid
pHF454 (2 µm TRP1) (see "Experimental Procedures"),
and the constructs were transformed into strains XCY101
(imp1::HIS3) and JNY34 (imp2
)/pXC3
(imp2 (S41A)). Cells were then examined by pulse-chase
analysis. As shown in Fig. 5, none of the
mutational combinations led to a form of i-cyt
b2HA that could be cleaved by Imp2p, including
the (
1A
3I) form that was described earlier (Fig. 4B,
see lane A). Of particular interest is the (
1A
3A) double mutation. Whereas the natural substrate for Imp2p contained a
1 and
3 alanine, Imp2p was unable to cleave the double alanine form
of i-cyt b2HA (Fig. 5). In contrast,
Imp1p was able to cleave some forms of i-cyt
b2HA, including the wild-type species (
1N
3I) and two mutant species, (
1N
3A; Fig. 5) and (
1A
3I; Fig. 4A, see lane A). These two mutations demonstrated
that Imp1p can cleave a signal peptide containing alanine at the
1 or
3 position. However, introducing alanine at both positions of
i-cyt b2HA inhibited cleavage by
Imp1p (Fig. 5), demonstrating the importance of the
1 and
3 amino
acids in determining cleavage by Imp1p.

View larger version (40K):
[in a new window]
Fig. 5.
Effect of changing the
1 and
3 amino acids of
p-cyt b2. A series
of TRP1-based plasmids encoding the cyt
b2HA precursors containing the amino acid
changes listed at the top of the figure was introduced into strain
XCY101 (imp1::HIS3) (first three lanes)
and strain JNY34 (imp2
)/pXC3 (imp2 (S41A)
URA3) (last three lanes). Cells of these strains
and strain JNY34/pXC3 lacking the plasmid encoding the cyt
b2-HA precursor (middle lane) were
subjected to a 10-min pulse and a 60-min chase, and proteins were
precipitated using anti-HA antibodies. The intermediate (i)
and mature (m) forms of cyt b2 are
indicated. Proteins were resolved on a 7% SDS-PAGE gel. Each lane
represents two A600 equivalents of log-phase
yeast cells.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 position directs
signal peptides to Imp1p and away from Imp2p. We have substituted the
1 asparagine of i-cyt b2 with 19 amino acids and then examined the mutant signal peptides for cleavage
by Imp1p (Fig. 4A) and Imp2p (Fig. 4B). The data
reveal that five different amino acids can be introduced into the
1 position of i-cyt b2 without
appreciable loss of cleavage efficiency by Imp1p. The amino acids
tolerated are serine, cysteine, methionine, alanine, and leucine.
Including the naturally occurring amino acid, asparagine, this group
includes polar (asparagine, serine, and cysteine) and nonpolar
(methionine, alanine, and leucine) amino acids and amino acids with
varying side-chain lengths. Both of the sulfur-containing amino acids
(cysteine and methionine) are permitted. Surprisingly, the alanine
substitution is recognized by Imp1p, despite the fact that the Imp2p
substrate, i-cyt c1, contains a
1
alanine. Indeed, alanine, serine, cysteine, and leucine have been seen
at the
1 positions of signal peptides targeted to the ER membrane
(29-31). From the fact that Imp1p can cleave these signal peptides and
cleave the highly unusual signal peptides containing asparagine and
methionine at the
1 position, we conclude that Imp1p is capable of
processing signal peptides exhibiting both standard and nonstandard
cleavage sites.
1 position of
i-cyt b2 produce signal peptides that
are recognized poorly or not at all by Imp1p (Fig. 4A).
Signal peptides containing glutamine and threonine are cleaved to a
small extent, and the remaining amino acid substitutions are not
recognized, including the substitutions of the aromatic and charged
amino acids and substitutions of proline, glycine, isoleucine, and
valine. The absence of efficient cleavage of 14 mutant signal pepides thus argues strongly against the idea that cleavage can occur at a
nearby asparagine.
1 position, Imp2p cannot cleave
i-cyt b2 containing a
1 alanine (Fig. 4B). In fact, Imp2p cannot cleave i-cyt
b2 regardless of the amino acid present at the
1 position. This argues against the hypothesis that asparagine is
responsible for directing signal peptides toward Imp1p and away from
Imp2p. During the course of this study, we noted that Imp1p substrates
i-cyt b2 and p-cyt oxidase
subunit II contain a
3 isoleucine, whereas the Imp2p substrate,
i-cyt c1, contains a
3 alanine.
Because the
3 position is thought to be important for signal peptide
recognition in the ER and eubacterial systems (2, 29-31), we
constructed another series of mutations, changing the
1 and
3 amino
acids of i-cyt b2. However, not even
i-cyt b2 containing alanine at both
the
1 and
3 positions could be cleaved by Imp2p (Fig. 5).
1 and
3 positions are important for proper cleavage of the signal peptide
of i-cyt b2. In contrast to previous
models, however, a
1 asparagine is not required to direct signal
peptides to Imp1p. Because the attachment of heme c to the
i-cyt c1 apoprotein is essential for
cleavage of this substrate by Imp2p (28), and the heme binding domain
of i-cyt b2 is needed for its
efficient cleavage by Imp1p (32, 33), current studies are focused on determining whether the mature portions of these proteins are important
for their recognition by specific IMP subunits.
| |
ACKNOWLEDGEMENT |
|---|
We thank Jodi Nunnari (University of California, Davis, CA) for providing yeast strains.
| |
FOOTNOTES |
|---|
* This work was supported by Department of Health and Human Services Training Grant 2 T32 CA09385-11 (to C. V.) and by grants from the National Science Foundation (to H. F. and N. G.) and American Heart Association (to N. G.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 615-343-0453;
Fax: 615-343-7392; E-mail: neil.green@mcmail.vanderbilt.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: ER, endoplasmic reticulum; PAGE, polyacrylamide gel electrophoresis; IMP, inner membrane protease; cyt, cytochrome; HA, hemagglutinin.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Dalbey, R. E., Lively, M. O., Bron, S., and van Dijl, J. M. (1997) Protein Sci. 6, 1129-1138[Abstract] |
| 2. | Paetzel, M., Dalbey, R. E., and Strynadka, N. C. J. (1998) Nature 396, 186-190[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Van Valkenburgh, C.,
Chen, X.,
Mullins, C.,
Fang, H.,
and Green, N.
(1999)
J. Biol. Chem.
274,
11519-11525 |
| 4. | Pratje, E., and Guiard, B. (1986) EMBO J. 5, 1313-1317[Medline] [Order article via Infotrieve] |
| 5. |
Nunnari, J.,
Fox, T. D.,
and Walter, P.
(1993)
Science
262,
1997-2004 |
| 6. |
Schneider, A.,
Opplinger, W.,
and Jeno, P.
(1994)
J. Biol. Chem.
269,
8635-8638 |
| 7. | Perlman, D., and Halvorson, H. O. (1983) J. Mol. Biol. 167, 391-409[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | von Heijne, G. (1983) Eur. J. Biochem. 133, 17-21[Medline] [Order article via Infotrieve] |
| 9. |
von Heijne, G.
(1986)
Nucleic Acids Res.
14,
4683-4690 |
| 10. |
Folz, R. J.,
Nothwehr, S. F.,
and Gordon, J. I.
(1988)
J. Biol. Chem.
263,
2070-2078 |
| 11. |
Fikes, J. D.,
Barkocy-Gallagher, G. A.,
Klapper, D. G.,
and Bassford, P. J., Jr.
(1990)
J. Biol. Chem.
265,
3417-3423 |
| 12. | Shen, L. M., Lee, J. I., Cheng, S. Y., Jutte, H., Kuhn, A., and Dalbey, R. E. (1991) Biochemistry 30, 11775-11781[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Green, N.,
and Walter, P.
(1992)
Mol. Cell. Biol.
12,
276-282 |
| 14. |
Herman, P. K.,
and Emr, S. D.
(1990)
Mol. Cell. Biol.
10,
6742-6754 |
| 15. |
Mullins, C.,
Lu, Y.,
Campbell, A.,
Fang, H.,
and Green, N.
(1995)
J. Biol. Chem.
270,
17139-17147 |
| 16. | Wilson, I. A., Niman, H. L., Houghten, R. A., Cherenson, A. R., Connolly, M. L., and Lerner, R. A. (1984) Cell 37, 767-778[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Bennetzen, J. L.,
and Hall, B. D.
(1982)
J. Biol. Chem.
257,
3018-3025 |
| 18. | Christianson, T. W., Sikorski, R. S., Dante, M., Shero, J. H., and Hieter, P. (1992) Gene (Amst.) 110, 119-122[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Sung, M.,
and Dalbey, R. E.
(1992)
J. Biol. Chem.
267,
13154-13159 |
| 20. |
Black, M. T.
(1993)
J. Bacteriol.
175,
4957-4961 |
| 21. |
Tschantz, W. R.,
Sung, M.,
Delgado-Partin, V. M.,
and Dalbey, R. E.
(1993)
J. Biol. Chem.
268,
27349-27354 |
| 22. |
van Dijl, J. M.,
de Jong, A.,
Venema, G.,
and Bron, S.
(1995)
J. Biol. Chem.
270,
3611-3618 |
| 23. |
Gasser, S. M.,
Ohashi, A.,
Daum, G.,
Bohni, P. C.,
Gibson, J.,
Reid, G.,
Yonetani, T.,
and Schatz, G.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
267-271 |
| 24. | Witte, C., Jensen, R. E., Yaffe, M. P., and Schatz, G. (1988) EMBO J. 7, 1439-1447[Medline] [Order article via Infotrieve] |
| 25. | Yang, M., Jensen, R. E., Yaffe, M. P., Opooliger, W., and Schatz, G. (1988) EMBO J. 7, 3857-3862[Medline] [Order article via Infotrieve] |
| 26. | Jensen, R. E., and Yaffe, M. P. (1988) EMBO J. 7, 3863-3871[Medline] [Order article via Infotrieve] |
| 27. | Luciano, P., and Geli, V. (1996) Experientia 56, 1077-1082 |
| 28. |
Ohashi, A.,
Gibson, J.,
Gregor, I.,
and Schatz, G.
(1982)
J. Biol. Chem.
257,
13042-13047 |
| 29. | von Heijne, G. (1983) Eur. J. Biochem. 133, 17-21 |
| 30. | von Heijne, G. (1985) J. Mol. Biol. 184, 99-105[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | von Heijne, G., and Abrahmsen, L. (1989) FEBS Lett. 244, 439-446[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Glick, B. S., Wachter, C., Reid, G. A., and Schatz, G. (1993) Protein Sci. 2, 1901-1917[Abstract] |
| 33. | Stuart, R. A., Gruhler, A., van der Klei, I., Guiard, B., Koll, H., and Neupert, W. (1994) Eur. J. Biochem. 220, 9-18[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
O. D. Ekici, A. Karla, M. Paetzel, M. O. Lively, D. Pei, and R. E. Dalbey Altered -3 Substrate Specificity of Escherichia coli Signal Peptidase 1 Mutants as Revealed by Screening a Combinatorial Peptide Library J. Biol. Chem., January 5, 2007; 282(1): 417 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Burri, Y. Strahm, C. J. Hawkins, I. E. Gentle, M. A. Puryer, A. Verhagen, B. Callus, D. Vaux, and T. Lithgow Mature DIABLO/Smac Is Produced by the IMP Protease Complex on the Mitochondrial Inner Membrane Mol. Biol. Cell, June 1, 2005; 16(6): 2926 - 2933. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Karla, M. O. Lively, M. Paetzel, and R. Dalbey The Identification of Residues That Control Signal Peptidase Cleavage Fidelity and Substrate Specificity J. Biol. Chem., February 25, 2005; 280(8): 6731 - 6741. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liang, W. Luo, N. Green, and H. Fang Cargo Sequences Are Important for Som1p-dependent Signal Peptide Cleavage in Yeast Mitochondria J. Biol. Chem., September 17, 2004; 279(38): 39396 - 39400. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liang, C. VanValkenburgh, X. Chen, C. Mullins, L. Van Kaer, N. Green, and H. Fang Genetic Complementation in Yeast Reveals Functional Similarities between the Catalytic Subunits of Mammalian Signal Peptidase Complex J. Biol. Chem., December 19, 2003; 278(51): 50932 - 50939. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Luo, X. Chen, H. Fang, and N. Green Factors Governing Nonoverlapping Substrate Specificity by Mitochondrial Inner Membrane Peptidase J. Biol. Chem., February 7, 2003; 278(7): 4943 - 4948. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |